Immuno Oncology Congress (ESMO) 2017
congress program
The ESMO 2017 Congress, in partnership with the European Association for
Cancer Research (EACR), created an environment where cancer researchers
and clinicians came together to collaborate and exchange ideas. This
exciting partnership delivered a unique cancer congress in Europe with
huge scientific reach and the true potential to improve the lives of
cancer patients.
Highlights in Mesothelioma: Role of Immunotherapy in Second- and Third-Line of Treatment
- Date : 2017-09-08
- 1 0
Highlights in Gynaecological Cancers: Hight Quality Data From Randomised Trials
- Date : 2017-09-08
- 0 0
Highlights in Supportive and Palliative Care: Focus on Patient Reported Outcomes
- Date : 2017-09-08
- 0 0